Drugs / CT-1578
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01235871 | Aug 2010 → Mar 2011 | — | S*BIO | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CT-1578 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2035185 ↗ |
| Known as | ONX 0805 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2035185 ↗ |
| Known as | SB1578 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01235871 ↗ |
| Action | Inhibit | “Macrophage colony stimulating factor receptor inhibitor” CHEMBL2035185 ↗ |
| Modality | Small molecule | — CHEMBL2035185 ↗ |
| Route | Oral | “Administered Orally” NCT01235871 ↗ |
| Target | CSF1R | “Macrophage colony stimulating factor receptor inhibitor” CHEMBL2035185 ↗ |
| Target | FLT3 | “Tyrosine-protein kinase receptor FLT3 inhibitor” CHEMBL2035185 ↗ |
| Target | JAK2 | “JAK2 Inhibitor” NCT01235871 ↗ |